Abstract
We evaluated the utility of performing predischarge implantable cardioverter-defibrillator (ICD) testing and ICD testing at 1 month in detecting ICD-related problems, identifying 4 patients with an unacceptable increase in defibrillation threshold. Given that ICD testing is noninvasive and has minimal (if any) associated risk, we recommend that predischarge and 1-month follow-up ICD testing should be performed after implantation.
Original language | English (US) |
---|---|
Pages (from-to) | 822-826 |
Number of pages | 5 |
Journal | American Journal of Cardiology |
Volume | 79 |
Issue number | 6 |
DOIs | |
State | Published - Mar 15 1997 |
Externally published | Yes |
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine